{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:13:51Z","timestamp":1790410431726,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.jcv.2012.07.013","type":"journal-article","created":{"date-parts":[[2012,8,9]],"date-time":"2012-08-09T14:02:36Z","timestamp":1344520956000},"page":"256-261","source":"Crossref","is-referenced-by-count":19,"title":["Comparison of INNO-LiPA Genotyping Extra and Hybrid Capture 2 assays for detection of carcinogenic human papillomavirus genotypes"],"prefix":"10.1016","volume":"55","author":[{"given":"Luisa","family":"Barzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Militello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Pagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pal\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2012.07.013_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens. Part B. Biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-9378-3-14","article-title":"Italian Society for Virology Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention","volume":"3","author":"Barzon","year":"2008","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.jcv.2012.07.013_bib0015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/djq562","article-title":"Human papillomavirus testing in the prevention of cervical cancer","volume":"103","author":"Schiffman","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcv.2012.07.013_bib0020","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jnci\/dji187","article-title":"The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice","volume":"97","author":"Khan","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcv.2012.07.013_bib0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"New Technologies for Cervical Cancer screening (NTCC) Working Group Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0035","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(11)70188-7","article-title":"Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study","volume":"12","author":"Castle","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/ijc.26056","article-title":"Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening","volume":"130","author":"Rijkaart","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcv.2012.07.013_bib0045","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"issue":"Suppl. 3","key":"10.1016\/j.jcv.2012.07.013_bib0050","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1386-6532(09)00540-X","article-title":"Validation of high-risk HPV tests for primary cervical screening","volume":"46","author":"Meijer","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0055","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1128\/JCM.00918-10","article-title":"WHO Human Papillomavirus Laboratory Network Global proficiency study of human papillomavirus genotyping","volume":"48","author":"Eklund","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0060","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1055-9965.EPI-07-2904","article-title":"A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study","volume":"17","author":"Gravitt","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jcv.2012.07.013_bib0065","first-page":"1394","article-title":"Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types","volume":"11","author":"Castle","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl. 3","key":"10.1016\/j.jcv.2012.07.013_bib0070","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S1386-6532(02)00187-7","article-title":"Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail","volume":"25","author":"Poljak","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0075","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/JCM.00824-08","article-title":"Human papillomavirus genotype specificity of hybrid capture 2","volume":"46","author":"Castle","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0080","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1128\/JCM.02580-06","article-title":"Costa Rican Vaccine Trial Group. Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5 683 young women in Guanacaste, Costa Rica","volume":"45","author":"Safaeian","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0085","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1128\/JCM.00476-08","article-title":"Comparison of GP5+\/6+-PCR and SPF10-line blot assays for detection of high-risk human papillomavirus in samples from women with normal cytology results who develop grade 3 cervical intraepithelial neoplasia","volume":"46","author":"Hesselink","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0090","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1128\/JCM.00918-10","article-title":"Global proficiency study of human papillomavirus genotyping","volume":"48","author":"Eklund","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0095","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1128\/JCM.06576-11","article-title":"Performance of commercial reverse line blot assay for human papillomavirus genotyping","volume":"50","author":"Steinau","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0100","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1002\/ijc.24224","article-title":"Investigation on the presence of polyomavirus, herpesvirus, and papillomavirus sequences in colorectal neoplasms and their association with cancer","volume":"124","author":"Militello","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcv.2012.07.013_bib0105","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcv.2009.01.006","article-title":"Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types","volume":"44","author":"Schmitz","year":"2009","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0110","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2303.2006.00386.x","article-title":"Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi","volume":"17","author":"Depuydt","year":"2006","journal-title":"Cytopathology"},{"key":"10.1016\/j.jcv.2012.07.013_bib0115","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1128\/JCM.00236-10","article-title":"Comparison of real-time multiplex human papillomavirus (HPV) PCR assays with INNO-LiPA HPV genotyping extra assay","volume":"49","author":"Else","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0120","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jcv.2004.08.009","article-title":"Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10\/LiPA","volume":"32","author":"Perrons","year":"2005","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0125","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/jmv.21733","article-title":"Distribution of human papillomavirus types in the anogenital tract of females and males","volume":"82","author":"Barzon","year":"2010","journal-title":"J Med Virol"},{"key":"10.1016\/j.jcv.2012.07.013_bib0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcv.2011.07.006","article-title":"Human papillomavirus genotyping by 454 next generation sequencing technology","volume":"52","author":"Barzon","year":"2011","journal-title":"J Clin Virol"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653212002661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653212002661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T17:44:31Z","timestamp":1562089471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653212002661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1386653212002661"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2012.07.013","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}